Is Helixate® FS safe?
A. Yes. In clinical studies involving previously treated patients, no inhibitor formation was detected. In clinical studies involving previously untreated patients, 15% developed inhibitors to Helixate® FS. There were no viral transmissions in any of the patients. Adverse events such as local injection site reaction, nausea, dizziness, and rash were reported in <1% of the patients.